Ribosome phenotypes for rapid classification of antibiotic-susceptible and resistant strains of Escherichia coli
Rapid antibiotic susceptibility tests (ASTs) are an increasingly important part of clinical care as antimicrobial resistance (AMR) becomes more common in bacterial infections. Here, we use the spatial distribution of fluorescently labelled ribosomes to detect intracellular changes associated with antibiotic susceptibility in E. coli cells using a convolutional neural network (CNN). By using ribosome-targeting probes, one fluorescence image provides data for cell segmentation and susceptibility phenotyping. Using 60,382 cells from an antibiotic-susceptible laboratory strain of E. coli, we showed that antibiotics with different mechanisms of action result in distinct ribosome phenotypes, which can be identified by a CNN with high accuracy (99%, 98%, 95%, and 99% for ciprofloxacin, gentamicin, chloramphenicol, and carbenicillin). With 6 E. coli strains isolated from bloodstream infections, we used 34,205 images of ribosome phenotypes to train a CNN that could classify susceptible cells with 91% accuracy and resistant cells with 99% accuracy. Such accuracies correspond to the ability to differentiate susceptible and resistant samples with 99% confidence with just 2 cells, meaning that this method could eliminate lengthy culturing steps and could determine susceptibility with 30 min of antibiotic treatment. The ribosome phenotype method should also be able to identify phenotypes in other strains and species.
Authors
- Monique Andersson (ORCID: https://orcid.org/0000-0003-0619-1074)
- Nicole Stoesser (ORCID: https://orcid.org/0000-0002-4508-7969)
- Achillefs N. Kapanidis (ORCID: https://orcid.org/0000-0001-6699-136X)
- Christoffer Nellåker (ORCID: https://orcid.org/0000-0002-2887-2068)
- Alison Farrar (ORCID: https://orcid.org/0000-0002-6849-3353)
- Conor Feehily (ORCID: https://orcid.org/0000-0002-1253-7353)
- Stelios Chatzimichail (ORCID: https://orcid.org/0000-0001-5289-3208)
- Sarah Oakley (ORCID: https://orcid.org/0000-0002-2484-8247)
- Lucinda Barrett (ORCID: https://orcid.org/0000-0002-5680-322X)
- Piers Turner (ORCID: https://orcid.org/0000-0002-3644-0636)
- Hafez El Sayyed (ORCID: https://orcid.org/0000-0002-7550-4428)
- Derrick W. Crook (ORCID: https://orcid.org/0000-0002-0590-2850)
- Sammi Ta
Institutions
- John Radcliffe Hospital (GB)
- Public Health England (GB)
- University of Oxford (GB)
- CRUK/MRC Oxford Institute for Radiation Oncology (GB)
- Oxford BioMedica (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Communications Biology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1038/s42003-025-07740-6
- Citations
- 6
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 6.59
Funders
- Wellcome
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Oxford Martin School, University of Oxford